Cellectis SA (ALCLS) - Medical Equipment - Deals and Alliances Profile

GlobalData
33 Pages - GLDATA61667
$250.00

Summary

Cellectis SA (Cellectis) is a biopharmaceutical company that offers therapeutic treatment. The company develops treatment based on allogeneic T-cell for the treatment of cancer. Its therapeutic pipeline products include products for hematopoietic tumors such as UCART19, UCART123, UCART33, UCART-BCMA and UCART38; and products for solid tumors include UCART5T4, UCART-EgfrVIII, s-3, s-4, s-5,s-6, and s-7. Cellectis conducts research and development in the field of oncology and gene editing. The company’s engineered T cell can convert a process to a T cell product, resist standard of care and overcome checkpoint inhibitions. Cellectis is headquartered in Paris, France.

Cellectis SA (ALCLS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cellectis SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cellectis SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cellectis SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cellectis SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cellectis SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cellectis SA, Medical Equipment, Deal Details 10
Partnerships 10
Cellectis bioresearch Enters Into Technology Integration Agreement With Stemgent 10
CYTOO, Cellectis Bioresearch Enter Into Co-Development Agreement With CEA 10
Equity Offering 11
Cellectis Prices Public Offering of American Depositary Shares for USD228.25 Million 11
Cellectis Completes Private Placement Of Shares For US$28.3 Million 13
Acquisition 14
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 14
Cellectis SA - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Mar 06, 2017: Cellectis Reports 4th Quarter and Full Year 2016 Financial Results 19
Nov 22, 2016: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016 22
Sep 08, 2016: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results 25
May 11, 2016: Cellectis Reports First Quarter 2016 Financial Results 28
Mar 14, 2016: Cellectis Reports Fourth Quarter and Full Year 2015 Financial Results 30
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Cellectis SA, Medical Equipment, Key Facts, 2015 1
Cellectis SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cellectis SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cellectis SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cellectis SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cellectis SA, Deals By Market, 2011 to YTD 2017 8
Cellectis SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cellectis bioresearch Enters Into Technology Integration Agreement With Stemgent 10
CYTOO, Cellectis Bioresearch Enter Into Co-Development Agreement With CEA 10
Cellectis Prices Public Offering of American Depositary Shares for USD228.25 Million 11
Cellectis Completes Private Placement Of Shares For US$28.3 Million 13
Pfizer May Acquire Remaining 90.5% Stake in Cellectis 14
Cellectis SA, Key Competitors 16
Cellectis SA, Key Employees 17
Cellectis SA, Subsidiaries 18

List of Figures
Cellectis SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cellectis SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cellectis SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cellectis SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cellectis SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cellectis SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Cellectis SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cellectis SA, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838